التفاصيل البيبلوغرافية
| العنوان: |
UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. |
| المؤلفون: |
Field, J. K., Duffy, S. W., Baldwin, D. R., Whynes, D. K., Devaraj, A., Brain, K. E., Eisen, T., Gosney, J., Green, B. A., Holemans, J. A., Kavanagh, T., Kerr, K. M., Ledson, M., Lifford, K. J., McRonald, F. E., Nair, A., Page, R. D., Parmar, M. K. B., Rassl, D. M., Rintoul, R. C. |
| المصدر: |
Thorax; Feb2016, Vol. 71 Issue 2, p161-170, 10p, 1 Black and White Photograph, 2 Diagrams, 4 Charts, 1 Graph |
| مصطلحات موضوعية: |
MEDICAL screening, LUNG cancer diagnosis, CANCER-related mortality, RANDOMIZED controlled trials, PREVENTION, COMPARATIVE studies, COMPUTED tomography, LUNG tumors, RESEARCH methodology, MEDICAL cooperation, PROGNOSIS, RESEARCH, RESEARCH evaluation, PILOT projects, EVALUATION research, DISEASE prevalence, EARLY detection of cancer, DIAGNOSIS |
| مصطلحات جغرافية: |
UNITED Kingdom |
| مستخلص: |
Background: Lung cancer screening using low-dose CT (LDCT) was shown to reduce lung cancer mortality by 20% in the National Lung Screening Trial.Methods: The pilot UK Lung Cancer Screening (UKLS) is a randomised controlled trial of LDCT screening for lung cancer versus usual care. A population-based questionnaire was used to identify high-risk individuals. CT screen-detected nodules were managed by a pre-specified protocol. Cost effectiveness was modelled with reference to the National Lung Cancer Screening Trial mortality reduction.Results: 247 354 individuals aged 50-75 years were approached; 30.7% expressed an interest, 8729 (11.5%) were eligible and 4055 were randomised, 2028 into the CT arm (1994 underwent a CT). Forty-two participants (2.1%) had confirmed lung cancer, 34 (1.7%) at baseline and 8 (0.4%) at the 12-month scan. 28/42 (66.7%) had stage I disease, 36/42 (85.7%) had stage I or II disease. 35/42 (83.3%) had surgical resection. 536 subjects had nodules greater than 50 mm(3) or 5 mm diameter and 41/536 were found to have lung cancer. One further cancer was detected by follow-up of nodules between 15 and 50 mm(3) at 12 months. The baseline estimate for the incremental cost-effectiveness ratio of once-only CT screening, under the UKLS protocol, was £8466 per quality adjusted life year gained (CI £5542 to £12 569).Conclusions: The UKLS pilot trial demonstrated that it is possible to detect lung cancer at an early stage and deliver potentially curative treatment in over 80% of cases. Health economic analysis suggests that the intervention would be cost effective-this needs to be confirmed using data on observed lung cancer mortality reduction.Trial Registration: ISRCTN 78513845. [ABSTRACT FROM AUTHOR] |
|
Copyright of Thorax is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
